Your browser doesn't support javascript.
loading
Dual pathway inhibition in patients with atherosclerotic disease: pharmacodynamic considerations and clinical implications.
Galli, Mattia; Franchi, Francesco; Rollini, Fabiana; Ortega-Paz, Luis; D'Amario, Domenico; De Caterina, Raffaele; Mehran, Roxana; Gibson, C Michael; Angiolillo, Dominick J.
Afiliação
  • Galli M; Catholic University of the Sacred Heart, Rome, Italy.
  • Franchi F; Maria Cecilia Hospital, GVM Care & Research, Cotignola, Italy.
  • Rollini F; Division of Cardiology, University of Florida College of Medicine, Jacksonville, Florida, United States.
  • Ortega-Paz L; Division of Cardiology, University of Florida College of Medicine, Jacksonville, Florida, United States.
  • D'Amario D; Division of Cardiology, University of Florida College of Medicine, Jacksonville, Florida, United States.
  • De Caterina R; Department of Cardiovascular and Thoracic Sciences, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
  • Mehran R; University of Pisa and University Cardiology Division, Pisa University Hospital, Pisa, Italy.
  • Gibson CM; Fondazione VillaSerena per la Ricerca, Città Sant'Angelo, Pescara, Italy.
  • Angiolillo DJ; Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Expert Rev Clin Pharmacol ; 16(1): 27-38, 2023 Jan.
Article em En | MEDLINE | ID: mdl-36455906
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores da Agregação Plaquetária / Aterosclerose Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores da Agregação Plaquetária / Aterosclerose Idioma: En Ano de publicação: 2023 Tipo de documento: Article